ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,262 | +24.0% | 36,193 | +42.5% | 0.01% | +33.3% |
| Q2 2023 | $608,426 | +91.3% | 25,404 | +50.3% | 0.01% | +80.0% |
| Q1 2023 | $318,096 | +47.7% | 16,902 | +25.0% | 0.01% | +66.7% |
| Q4 2022 | $215,302 | -4.3% | 13,524 | -1.5% | 0.00% | -25.0% |
| Q3 2022 | $225,000 | +9.2% | 13,735 | -5.9% | 0.00% | +33.3% |
| Q2 2022 | $206,000 | -54.8% | 14,597 | -22.5% | 0.00% | -50.0% |
| Q1 2022 | $456,000 | +12.6% | 18,837 | +8.5% | 0.01% | +20.0% |
| Q4 2021 | $405,000 | +10.1% | 17,359 | -21.6% | 0.01% | 0.0% |
| Q3 2021 | $368,000 | -47.4% | 22,138 | -22.9% | 0.01% | -50.0% |
| Q2 2021 | $700,000 | -5.8% | 28,697 | -0.3% | 0.01% | -16.7% |
| Q1 2021 | $743,000 | -43.9% | 28,781 | +16.1% | 0.01% | -45.5% |
| Q4 2020 | $1,325,000 | +51.9% | 24,782 | +17.2% | 0.02% | +29.4% |
| Q3 2020 | $872,000 | +50.3% | 21,151 | +76.6% | 0.02% | +41.7% |
| Q2 2020 | $580,000 | +76.3% | 11,976 | +53.9% | 0.01% | +50.0% |
| Q1 2020 | $329,000 | +27.5% | 7,781 | +28.9% | 0.01% | +60.0% |
| Q4 2019 | $258,000 | +35.8% | 6,035 | +14.5% | 0.01% | +25.0% |
| Q3 2019 | $190,000 | +72.7% | 5,273 | +28.0% | 0.00% | +100.0% |
| Q2 2019 | $110,000 | -30.8% | 4,118 | -30.5% | 0.00% | -50.0% |
| Q1 2019 | $159,000 | +65.6% | 5,929 | +0.3% | 0.00% | +100.0% |
| Q4 2018 | $96,000 | +200.0% | 5,912 | +602.1% | 0.00% | +100.0% |
| Q3 2017 | $32,000 | -77.6% | 842 | -83.6% | 0.00% | -75.0% |
| Q2 2017 | $143,000 | -11.2% | 5,133 | +10.0% | 0.00% | -20.0% |
| Q1 2017 | $161,000 | – | 4,665 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |